Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort - NCT00344903-75390 (Clinical Trial 146162)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy146162.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Dallas |
|
State:
|
|
TX |
| Zip Code: |
|
75390 |
| Conditions: |
|
Atherosclerosis - Congestive Heart Failure - Left Ventricular Hypertrophy - Diabetes Mellitus - Hypertension - Obesity - Metabolic Syndrome X - Myocardial Infarction |
| Purpose: |
|
The Dallas Heart Study (DHS-1) is a large, multi-ethnic, population-based epidemiological
study designed to identify determinants of atherosclerotic heart disease (ASHD) in a
representative United States (US) urban environment. This study completed enrollment in
2003.
Our objective is to pinpoint factors contributing to progression:
1. from health to ASHD risk;
2. from ASHD risk to subclinical ASHD; and
3. from subclinical to clinical ASHD.
Identification of the critical factors in these transitions will enable targeted
implementation of appropriate therapy to interdict before clinical ASHD develops.
|
| Study summary: |
|
Early medical intervention in asymptomatic individuals at risk is the most effective
strategy to combat atherosclerotic heart disease (ASHD). The major roadblock to effective
ASHD prevention is that conventional tools to assess ASHD risk are inadequate and new
methods are needed to identify susceptible individuals before the disease process is
established. Other successful public-health screening programs have incorporated direct
imaging procedures (e.g. mammography, colonoscopy); yet in ASHD, direct imaging of the
vasculature has not been incorporated into the risk stratification algorithms.
The Dallas Heart Study (DHS-1) is a large, multi-ethnic, population-based epidemiological
study designed to identify determinants of ASHD in a representative US urban environment.
This study completed enrollment in 2003.
In DHS-2 we will transform the Dallas Heart Study from a cross-sectional health survey
(DHS-1) into a longitudinal cohort study (DHS-2). We will perform state-of-the-art
cardiovascular (CV) imaging coupled to biomarkers, genetic markers and classical ASHD risk
factors. We will repeat the detailed clinical phenotyping performed between 2000-2003 to
capture interval changes in ASHD risk and disease burden. Our objective is to pinpoint
factors contributing to progression:
1. from health to ASHD risk;
2. from ASHD risk to subclinical ASHD; and
3. from subclinical to clinical ASHD.
Identification of the critical factors in these transitions will enable targeted
implementation of appropriate therapy to interdict before clinical ASHD develops. |
| Criteria: |
|
Inclusion Criteria:
- Age 35-70
- Participant in DHS-1 study completing visit 2 (blood sampling) and visit 3 (clinic
visit)
- Provision of informed consent
Exclusion Criteria:
- None--population study |
|
|
|
| Study is available at: |
|
UT Southwestern Medical Center
Dallas, TX 75390
United States
Primary Contact:
Kate Wilikinson, MS
Email: kathleen.wilkinson@utsouthwestern.edu
Phone: 214-648-1438 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
November 15, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|